Login / Signup

Mitochondrial complex I deficiency stratifies idiopathic Parkinson's disease.

Irene H FlønesLilah TokerDagny Ann SandnesMartina CastelliSepideh MostafaviNjål LuraOmnia ShadadErika Fernández-VizarraCèlia PainousAlexandra Pérez-SorianoYaroslau ComptaLaura Molina-PorcelGuido Werner AlvesOle-Bjørn TysnesChristian DölleGonzalo S NidoCharalampos Tzoulis
Published in: Nature communications (2024)
Idiopathic Parkinson's disease (iPD) is believed to have a heterogeneous pathophysiology, but molecular disease subtypes have not been identified. Here, we show that iPD can be stratified according to the severity of neuronal respiratory complex I (CI) deficiency, and identify two emerging disease subtypes with distinct molecular and clinical profiles. The CI deficient (CI-PD) subtype accounts for approximately a fourth of all cases, and is characterized by anatomically widespread neuronal CI deficiency, a distinct cell type-specific gene expression profile, increased load of neuronal mtDNA deletions, and a predilection for non-tremor dominant motor phenotypes. In contrast, the non-CI deficient (nCI-PD) subtype exhibits no evidence of mitochondrial impairment outside the dopaminergic substantia nigra and has a predilection for a tremor dominant phenotype. These findings constitute a step towards resolving the biological heterogeneity of iPD with implications for both mechanistic understanding and treatment strategies.
Keyphrases
  • magnetic resonance
  • parkinson disease
  • magnetic resonance imaging
  • single cell
  • dna methylation
  • cerebral ischemia
  • brain injury
  • blood brain barrier
  • mitochondrial dna
  • respiratory tract
  • smoking cessation